Adding the direct-acting hepatitis C drug simeprevir to pegylated interferon and ribavirin produced high response rates for HIV positive people coinfected with HCV genotype 1 or 4, researchers reported at the 14th European AIDS Conference this week in Brussels.
http://www.hivandhepatitis.com/hcv-treatment/experimental-hcv-drugs/4367-eacs-2013-simeprevir-with-interferon-effective-for-hivhcv-coinfected-people-with-genotype-1-or-4
http://www.hivandhepatitis.com/hcv-treatment/experimental-hcv-drugs/4367-eacs-2013-simeprevir-with-interferon-effective-for-hivhcv-coinfected-people-with-genotype-1-or-4
No comments:
Post a Comment